143 related articles for article (PubMed ID: 12207167)
1. Normal progression of testicular size in boys with idiopathic short stature and isolated growth hormone deficiency treated with growth hormone: experience from the KIGS.
Lindgren AC; Chatelain P; Lindberg A; Price DA; Ranke MB; Reiter EO; Wilton P;
Horm Res; 2002; 58(2):83-7. PubMed ID: 12207167
[TBL] [Abstract][Full Text] [Related]
2. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
Reiter EO; Lindberg A; Ranke MB; Price DA; Albertsson-Wikland K; Cowell CT; Bakker B
Horm Res; 2003; 60(Suppl 1):68-73. PubMed ID: 12955021
[TBL] [Abstract][Full Text] [Related]
3. Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study.
Ranke MB; Price DA; Albertsson-Wikland K; Maes M; Lindberg A
Horm Res; 1997; 48(2):62-71. PubMed ID: 9251922
[TBL] [Abstract][Full Text] [Related]
4. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database.
Reiter EO; Price DA; Wilton P; Albertsson-Wikland K; Ranke MB
J Clin Endocrinol Metab; 2006 Jun; 91(6):2047-54. PubMed ID: 16537676
[TBL] [Abstract][Full Text] [Related]
5. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA
J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
[TBL] [Abstract][Full Text] [Related]
6. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
[TBL] [Abstract][Full Text] [Related]
7. Response to growth hormone with respect to pubertal status on increased dose in idiopathic growth hormone deficiency: an analysis of Turkish children in the KIGS database (Pfizer International Growth Study).
Darendeliler F; Berberoğlu M; Ocal G; Adiyaman P; Bundak R; Günöz H; Baş F; Darcan S; Gökşen D; Arslanoğlu I; Yildiz M; Ercan O; Ercan G; Ozerkan E; Can S; Böber E; Adal E; Sarikaya S; Dallar Y; Siklar Z; Bircan I; Bideci A; Yüksel B; Büyükgebiz A
J Pediatr Endocrinol Metab; 2005 Oct; 18(10):949-54. PubMed ID: 16355808
[TBL] [Abstract][Full Text] [Related]
8. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
Child CJ; Quigley CA; Cutler GB; Moore WV; Wintergerst KA; Ross JL; Rosenfeld RG; Blum WF
Horm Res Paediatr; 2019; 91(4):241-251. PubMed ID: 31185471
[TBL] [Abstract][Full Text] [Related]
9. Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board.
Cutfield W; Lindberg A; Albertsson Wikland K; Chatelain P; Ranke MB; Wilton P
Acta Paediatr Suppl; 1999 Feb; 88(428):72-5. PubMed ID: 10102057
[TBL] [Abstract][Full Text] [Related]
10. Amino-terminal propeptide of C-type natriuretic peptide and linear growth in children: effects of puberty, testosterone, and growth hormone.
Olney RC; Prickett TC; Yandle TG; Espiner EA; Han JC; Mauras N
J Clin Endocrinol Metab; 2007 Nov; 92(11):4294-8. PubMed ID: 17684048
[TBL] [Abstract][Full Text] [Related]
11. Reference curve for the first-year growth response to growth hormone treatment in prepubertal children with idiopathic growth hormone deficiency: validation of the KIGS first-year growth response curve using the Belgian Register for the Study of Growth and Puberty Problems.
Straetemans S; Roelants M; Thomas M; Rooman R; De Schepper J
Horm Res Paediatr; 2014; 81(5):343-9. PubMed ID: 24686034
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort.
Maghnie M; Ranke MB; Geffner ME; Vlachopapadopoulou E; Ibáñez L; Carlsson M; Cutfield W; Rooman R; Gomez R; Wajnrajch MP; Linglart A; Stawerska R; Clayton PE; Darendeliler F; Hokken-Koelega ACS; Horikawa R; Tanaka T; Dörr HG; Albertsson-Wikland K; Polak M; Grimberg A
J Clin Endocrinol Metab; 2022 Nov; 107(12):3287-3301. PubMed ID: 36102184
[TBL] [Abstract][Full Text] [Related]
13. Short boys treated with growth hormone show normal progression of testicular size and achieve normal serum testosterone concentrations.
Ankarberg-Lindgren C; Norjavaara E; Wikland KA
Eur J Endocrinol; 2002 May; 146(5):681-5. PubMed ID: 11980624
[TBL] [Abstract][Full Text] [Related]
14. Effect of growth hormone treatment on testicular function, puberty, and adrenarche in boys with non-growth hormone-deficient short stature: a randomized, double-blind, placebo-controlled trial.
Leschek EW; Troendle JF; Yanovski JA; Rose SR; Bernstein DB; Cutler GB; Baron J
J Pediatr; 2001 Mar; 138(3):406-10. PubMed ID: 11241051
[TBL] [Abstract][Full Text] [Related]
15. Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. Genentech Collaborative Group.
Veldhuis JDP6 ; Blizzard RM; Rogol AD; Martha PM; Kirkland JL; Sherman BM
J Clin Endocrinol Metab; 1992 Apr; 74(4):766-73. PubMed ID: 1548338
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of craniofacial growth in idiopathic short stature and growth hormone-deficient boys treated with growth hormone.
Kjellberg H; Wikland KA
Eur J Orthod; 2007 Jun; 29(3):243-50. PubMed ID: 17513878
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone treatment of idiopathic short stature.
Hintz RL
Horm Res; 1996; 46(4-5):208-14. PubMed ID: 8950623
[TBL] [Abstract][Full Text] [Related]
18. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
[TBL] [Abstract][Full Text] [Related]
19. Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review.
Ranke MB; Lindberg A
Horm Res Paediatr; 2011; 75(6):423-32. PubMed ID: 21358173
[TBL] [Abstract][Full Text] [Related]
20. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
